Fred Alger Management »

Terns Pharmaceuticals shares owned by Fred Alger Management

Quarter-by-quarter ownership of Terns Pharmaceuticals (TERN) shares owned by Fred Alger Management from 13F filings

Historical chart of Fred Alger Management investment in Terns Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Terns Pharmaceuticals held by Fred Alger Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Terns Pharmaceuticals by Fred Alger Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $2.5M 47k 52.72
2025-12-31 $3.6M 90k 40.40
2023-03-31 $193k 16k 11.84

More positions owned by Fred Alger Management

NVIDIA Corporation Equity (NVDA)
Microsoft Corporation Equity (MSFT)
Amazon.com Equity (AMZN)
Apple Equity (AAPL)
Alphabet Inc. Class C Equity (GOOG)
Meta Platforms Inc Class A Equity (META)
Nebius Group N.V. Class A Equity (NBIS)
Broadcom Equity (AVGO)
Western Digital Corporation Equity (WDC)
Tesla Equity (TSLA)
AppLovin Corp. Class A Equity (APP)
Qxo Equity (QXO)
Talen Energy Corp Equity (TLN)
Natera Equity (NTRA)
GE Vernova Equity (GEV)

View all positions for Fred Alger Management

Top funds holding Terns Pharmaceuticals

BlackRock
Morgan Stanley
Adage Capital Partners GP
Vanguard Group
Vanguard Capital Management
venBio Select Advisor
Holocene Advisors
Balyasny Asset Management
Citadel Advisors
Millennium Management
HBK Investments
Lord, Abbett & Co
Ikarian Capital
Franklin Resources
Geode Capital Management

View all funds holding Terns Pharmaceuticals